Patent details
EP2535354
Title:
ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
Basic Information
- Publication number:
- EP2535354
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP121700520
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
- French Title of Invention:
- Anticorps dirigés contre le récepteur humain de mort programmée PD-1
- German Title of Invention:
- Antikörper gegen den humanen programmed death Rezeptor PD-1
- SPC Number:
-
Dates
- Filing date:
- 13/06/2008
- Grant date:
- 11/01/2017
- EP Publication Date:
- 11/01/2017
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 19/12/2012
- EP B1 Publication Date:
- 11/01/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 13/06/2017
- Expiration date:
- 13/06/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/06/2008
-
-
- Name:
- Merck Sharp & Dohme B.V.
- Address:
- Waarderweg 39, 2031 BN Haarlem, Netherlands (NL)
Inventor
1
- Name:
- Dulos Gradus Johannes
- Address:
- Netherlands (NL)
2
- Name:
- Van Eenennaam Hans
- Address:
- Netherlands (NL)
3
- Name:
- Carven Gregory John
- Address:
- United States (US)
Priority
- Priority Number:
- 944583 P
- Priority Date:
- 18/06/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
C07K 16/28;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
| Filing date |
Document type |
Number of pages |